In this edition of Aesthetics Insider, host Steven Dayan, MD talks with Brent Saunders, CEO of Allergan. In March 2015, Actavis acquired Allergan in a $70 billion merger. Now, the newly combined company bears the Allergan name. Brent Saunders, often seen on CNBC and quoted in the Wall Street Journal, answers the questions that affect doctors. Mr. Saunders discusses the challenges of the merger, describes his management style, and discusses how to successfully bring two companies together under one roof. He answers Dr. Dayan's questions about innovation, R&D, and physician relationships.